Infectious Diseases Diagnostic is used for confirmation of a disease that can be spreaded in form of a quick, precise test result.
This report contains market size and forecasts of Infectious Diseases Diagnostic in Global, including the following market information:
Global Infectious Diseases Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Infectious Diseases Diagnostic market was valued at 16980 million in 2021 and is projected to reach US$ 21390 million by 2028, at a CAGR of 3.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Urine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Infectious Diseases Diagnostic include Becton Dickinson & Company, Cepheid, Inc., Abbott Laboratories, bioMerieux SA, Hologic, Inc., Danaher Corporation, Thermo Fisher Scientific, Inc., Roche Diagnostics and Alera Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Infectious Diseases Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Infectious Diseases Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Infectious Diseases Diagnostic Market Segment Percentages, by Type, 2021 (%)
Urine
Blood
Others
Global Infectious Diseases Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Infectious Diseases Diagnostic Market Segment Percentages, by Application, 2021 (%)
Hospitals and Trauma Centers
Diagnostic Laboratories
Rehabilitation Centers
Global Infectious Diseases Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Infectious Diseases Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Infectious Diseases Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Infectious Diseases Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Becton Dickinson & Company
Cepheid, Inc.
Abbott Laboratories
bioMerieux SA
Hologic, Inc.
Danaher Corporation
Thermo Fisher Scientific, Inc.
Roche Diagnostics
Alera Inc.
DiaSorin S.p.A.
Quidel Corporation
Bio-Rad Laboratories, Inc.